Connect with us

Covid -19

The price of the Corbevax Covid-19 vaccine has been reduced by Biological E. to ₹250 per dose

Published

on

The price of the Corbevax Covid-19 vaccine has been reduced by Biological E. to ₹250 per dose

Biological E. Ltd (BE) announced on Monday that the price of its Covid-19 vaccine Corbevax for private vaccination centres has been reduced to $250 from 840 per dose, inclusive of GST.

End users would pay $400 per dose, including taxes and administrative fees, according to the company in a statement.

Previously, the overall cost of the vaccine to end users in private vaccination centres was 990 per dose, including taxes and administration fees, it said.

When the country’s COVID-19 vaccination programme for children aged 12 to 14 years began in March, Corbevax vaccine was used, and its price was set at 145 for the government vaccination programme.

Advertisement

“BE has reduced the price of its vaccine in order to make it more affordable and to help expand its reach in order to protect the greatest number of children against the virus,” the company said.

The Emergency Use Authorization (EUA) for Biological E’s Corbevax for children aged 5 to 12 years and Bharat Biotech’s Covaxin for children aged 6 to 12 years was granted by India’s drug regulator in April this year.

Corbevax was developed in collaboration with Texas Children’s Hospital and Baylor College of Medicine. The company said it conducted Phase II and III multi-centre clinical trials in 624 children aged 5 to 12 and 12 to 18 years old before receiving EUA for vaccination.

Advertisement

Covid -19

Covid infection linked to more type 1 diabetes in kids and teens: Study

Published

on

By

Covid infection linked to more type 1 diabetes in kids and teens: Study

Two studies that did not definitively resolve the question of whether the coronavirus can cause the chronic disease of diabetes found that Covid-19 in children and adolescents appeared to increase the chance of acquiring diabetes. Over two years after the pandemic’s commencement, researchers from the Norwegian Institute of Public Health looked at new type 1 diabetes diagnoses using national health registries. They discovered that type 1 diabetes was roughly 60% more likely to develop in children who had tested positive for the coronavirus.

The risk within 30 days of a Covid infection confirmed by a PCR test was examined by the researchers. Young adults were also included in a Scottish study that was presented at the European Link for the Study of Diabetes meeting. This study indicated an increased risk one month following the viral sickness, but the researchers said they discovered no association after that point.

The authors of both studies emphasised that their findings do not necessarily imply a causal link between diabetes and the coronavirus. Other potential causes were emphasised, such as delays in seeking medical attention during the epidemic, the introduction of other diseases, and alterations in way of life brought on by lockdowns.

Jamie Hartmann-Boyce, an associate professor at the Nuffield department of primary care health sciences at the University of Oxford, stated: “There are a lot of plausible reasons that Covid-19 might lead to development of type 1 diabetes, but this remains in no way proved.”
According to a paper earlier this week in the medical journal The Lancet, the number of people with type 1 diabetes, in which the pancreas fails to generate the hormone insulin, may increase from 8.4 million to 17.4 million by the year 2040.

Advertisement

The illness, which has no known treatment and is most frequently diagnosed in children, is thought to be caused by a combination of genetics and exposure to particular pathogens, including SARS-Cov-2 as well as a larger family of viruses known as enteroviruses. Type 2 diabetes, which is more prevalent, typically appears later in life as sedentary habits and weight increase mess with the body’s ability to manage sugar.

Group Media Publications
Entertainment News Platforms – anyflix.in      
Construction Infrastructure and Mining News Platform – https://cimreviews.com/
General News Platform – https://ihtlive.com/
Legal and Laws News Platforms – https://legalmatters.in/
Podcast Platforms – https://anyfm.in/

Advertisement
Continue Reading
Anyskill-ads

Facebook

[the_ad id="55117"]

Trending